Research-backed articles on peptides, women's longevity, perimenopause science, and female biology. Written for Australian and New Zealand women who want real answers.
Most peptide research was conducted on men. Most protocols were designed for men. Here's the comprehensive guide Australian women have been waiting for.
BPC-157 is one of the most searched peptide compounds in Australia. Here's what the research actually shows — and why women's biology responds uniquely.
GHK-Cu influences the expression of over 4,000 human genes — and its natural levels decline with age. Here's what the research shows about collagen, skin, and why this compound matters for women post-perimenopause.
Brain fog, sleep disruption, skin changes, weight resistance. The perimenopause research gap is real — and peptide science is beginning to fill it.
NAD+ levels drop by up to 50% by midlife. For women, the consequences are disproportionate. Here's what the research shows and why it matters.
Epithalon is one of the few longevity peptides with published human clinical data — on telomere elongation, melatonin restoration, and biological age markers. Here's what Australian women need to know.
Retatrutide is the first triple GIP/GLP-1/glucagon receptor agonist with Phase 2 clinical data. For women navigating perimenopausal metabolic resistance, its mechanism maps directly onto the biology of that resistance.
Your Cart
Your cart is empty
Add a peptide to get started.